NCT05465772

Brief Summary

  1. 1.correlation between COVID-19 and Hypertension and/or kidney diseases.
  2. 2.Assess Assess the effect of COVID-19 on patients with Hypertension and/or kidney diseases.
  3. 3.Assess the effect of hypertension and/or kidney diseases on COVID-19 presentation.
  4. 4.Assess the outcome of COVID-19 in patients with hypertension and/or kidney diseases

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

July 18, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 20, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

July 20, 2022

Status Verified

July 1, 2022

Enrollment Period

2.1 years

First QC Date

July 18, 2022

Last Update Submit

July 18, 2022

Conditions

COVID-19HypertensionKidney Diseases

Outcome Measures

Primary Outcomes (1)

  • Covid-19 and Hypertension and/or kidney diseases

    Effect of COVID-19 on patients with Hypertension and/or kidney diseases and assess the outcome of COVID-19 in patients with hypertension and/or kidney diseases.

    Baseline

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to ICU with positive PCR with Hypertension and/or kidney diseases.

You may qualify if:

  • Patients above 18 years old. Patients who diagnosed as COVID-19 PCR positive with hypertension and/or kidney diseases.

You may not qualify if:

  • Young patients below 18 years old. Patients who refused to participate in reseach

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19HypertensionKidney Diseases

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesVascular DiseasesCardiovascular DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Aya Abdelrhman Kotb

CONTACT

01069555261ayaabdelrhman409@gmail.com

Atef farouk El-karn, Professor

CONTACT

01006474200Afaroukeg@yahoo.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

July 18, 2022

First Posted

July 20, 2022

Study Start

July 1, 2022

Primary Completion

August 1, 2024

Study Completion

October 1, 2024

Last Updated

July 20, 2022

Record last verified: 2022-07